Historical record - last NADAC effective date: 12/21/2022
Product Information
SM CHEST CONG RELIEF PE CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0697 per EA under NDC 49348077409. Its NADAC has been published 476 times since Nov 28, 2013.
Strength
400; 10 mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
49348077409
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
12/21/2022
Active Ingredients
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/5/2006
Pharmacological Classes
Price Statistics
The NADAC for SM CHEST CONG RELIEF PE CAPLET has been published 476 times since Nov 28, 2013, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0697 per EA |
|---|---|
| All-time high | $0.1044 (Jan 15, 2020) |
| All-time low | $0.0697 (Dec 21, 2022) |
| Median price | $0.0849 |
| Average price | $0.0845 |
| Largest weekly change | +26.3% (Jan 22, 2014) |
| Weeks tracked | 476 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-19.7%
All
-12.1%
Last surveyed Jan 4, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin/phenylephrine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SM CHEST CONG RELIEF PE CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for SM CHEST CONG RELIEF PE CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.0697 per EA (NDC 49348077409), effective Jan 4, 2023.
How has the price of SM CHEST CONG RELIEF PE CAPLET changed over time?
Over the history we have for it, the NADAC for SM CHEST CONG RELIEF PE CAPLET has declined 12.1%. It has been tracked across 476 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SM CHEST CONG RELIEF PE CAPLET?
Since Nov 28, 2013, the NADAC for SM CHEST CONG RELIEF PE CAPLET has ranged from a low of $0.0697 (Dec 21, 2022) to a high of $0.1044 (Jan 15, 2020), with a median of $0.0849 per EA.
Are there cheaper alternatives to SM CHEST CONG RELIEF PE CAPLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SM CHEST CONG RELIEF PE CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SM CHEST CONG RELIEF PE CAPLET?
SM CHEST CONG RELIEF PE CAPLET (NDC 49348077409) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.